Agri-NEO Inc

Grifols Canada Ltd, based in Mississauga, ON, is a global leader in biopharmaceuticals, diagnostics, and healthcare solutions, committed to improving the health and well-being of people worldwide since 1909. The company specializes in developing, producing, and marketing innovative medicines and services across more than 110 countries, with a strong focus on therapeutic areas such as immunology, neurology, and infectious diseases. With a dedication to sustainability and ethical leadership, Grifols actively supports patients and donor communities while striving to combat climate change. Their extensive research and development network fosters continuous innovation, enhancing the quality of life for individuals through advanced plasma-derived treatments and healthcare solutions. Generated from the website

Deep Genomics Inc., based in Toronto, is at the forefront of revolutionizing drug development through the integration of artificial intelligence and RNA biology. Their proprietary AI platform enables the identification of novel therapeutic targets and the programming of RNA therapies for a wide range of genetic conditions. Since unlocking their first targets in 2018, Deep Genomics has continued to expand its capabilities, including the development of Big RNA, which aims to tackle more complex genetic diseases. The company is dedicated to harnessing data-driven predictions to accelerate the discovery of valuable medicines and address the genetic challenges faced by individuals worldwide. Generated from the website

Anogen-Yes Biotech Laboratories Ltd., located in Mississauga, Canada, has been a leading provider of high-quality antibody-based products since its founding in 1989. With a robust portfolio of over 300 monoclonal and polyclonal antibodies and more than 60 types of ELISA kits, the company focuses on research, diagnostic, and therapeutic applications. Committed to excellence, Anogen's quality management system meets ISO13485:2016 standards, ensuring the delivery of superior products for biomedical research. The company also engages in ongoing research and development in areas such as inflammation, Alzheimer's disease, and cancer, contributing to advancements that may benefit patients and enhance medical outcomes. Generated from the website